Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?
Zecca C, Bellavia G, Brambilla L, Gutierrez LP, Gerardi C, Fiori AM, Bernardini LR, Camera G, Disanto G, Petrini L, Perugini J, Antozzi CG, Torri Clerici V, Bellino A, Confalonieri PA, Gobbi C, Mantegazza RE, Rossi S. Zecca C, et al. Among authors: rossi s. CNS Drugs. 2018 Jul;32(7):653-660. doi: 10.1007/s40263-018-0529-1. CNS Drugs. 2018. PMID: 29949101
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.
Mallucci G, Annovazzi P, Miante S, Torri-Clerici V, Matta M, La Gioia S, Cavarretta R, Mantero V, Costantini G, D'Ambrosio V, Zaffaroni M, Ghezzi A, Perini P, Rossi S, Bertolotto A, Rottoli MR, Rovaris M, Balgera R, Cavalla P, Montomoli C, Bergamaschi R. Mallucci G, et al. Among authors: rossi s. J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14. J Neurol. 2018. PMID: 29948245
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
Lugaresi A, Florio C, Brescia-Morra V, Cottone S, Bellantonio P, Clerico M, Centonze D, Uccelli A, di Ioia M, De Luca G, Marcellusi A, Paolillo A; BRIDGE study group. Lugaresi A, et al. BMC Neurol. 2012 Mar 5;12:7. doi: 10.1186/1471-2377-12-7. BMC Neurol. 2012. PMID: 22390218 Free PMC article. Clinical Trial.
Clinical activity after fingolimod cessation: disease reactivation or rebound?
Frau J, Sormani MP, Signori A, Realmuto S, Baroncini D, Annovazzi P, Signoriello E, Maniscalco GT, La Gioia S, Cordioli C, Frigeni B, Rasia S, Fenu G, Grasso R, Sartori A, Lanzillo R, Stromillo ML, Rossi S, Forci B, Cocco E; i-MuST study group. Frau J, et al. Among authors: rossi s. Eur J Neurol. 2018 Oct;25(10):1270-1275. doi: 10.1111/ene.13694. Epub 2018 Jul 10. Eur J Neurol. 2018. PMID: 29851435
Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
Solaro C, Trabucco E, Signori A, Martinelli V, Radaelli M, Centonze D, Rossi S, Grasso MG, Clemenzi A, Bonavita S, D'Ambrosio A, Patti F, D'Amico E, Cruccu G, Truini A. Solaro C, et al. Among authors: rossi s. PLoS One. 2016 Sep 15;11(9):e0160261. doi: 10.1371/journal.pone.0160261. eCollection 2016. PLoS One. 2016. PMID: 27632167 Free PMC article.
3,513 results